Jeffrey Stelk - Endologix Vice President - U.S. Sales
President
Mr. Jeffrey Stelk serves as Vice President U.S. Sales of the Company. Mr. Stelk has over 25 years of sales and sales management experience in the medical device industry, including more than 16 years in the endovascular repair industry with us and Medtronic. Mr. Stelk is currently responsible for leading and managing the U.S. sales organization. During his tenure with us, Mr. Stelk has held various roles of increasing responsibility, including as Regional Sales Manager, Area Sales Manager and Director of Sales. In these roles, Mr. Stelk delivered significant sales growth by launching multiple new products and hiring, training and developing members of our direct sales team since 2004.
| Age | 54 |
| Tenure | 20 years |
| Phone | 949 595-7200 |
| Web | http://endologix.com |
Endologix Management Efficiency
The company has return on total asset (ROA) of (9.82) % which means that it has lost $9.82 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (167.38) %, meaning that it created substantial loss on money invested by shareholders. Endologix's management efficiency ratios could be used to measure how well Endologix manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 195.94 M in liabilities with Debt to Equity (D/E) ratio of 3.67, implying the company greatly relies on financing operations through barrowing. Endologix has a current ratio of 0.38, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Endologix until it has trouble settling it off, either with new capital or with free cash flow. So, Endologix's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Endologix sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Endologix to invest in growth at high rates of return. When we think about Endologix's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Douglas Brinkworth | Suburban Propane Partners | 63 | |
| Daniel Perrone | Transportadora de Gas | N/A | |
| Michael Schueler | Suburban Propane Partners | 53 | |
| Cathy Mauzaize | ServiceNow | N/A | |
| Oscar Sardi | Transportadora de Gas | 69 | |
| Benjamin Guzman | Transportadora de Gas | N/A | |
| Sandra Zwickel | Suburban Propane Partners | 52 | |
| Michael Keating | Suburban Propane Partners | 61 | |
| Tracy Bridge | CenterPoint Energy | 59 | |
| Jason Wells | CenterPoint Energy | 46 | |
| Detlef Krause | ServiceNow | N/A | |
| Scott Doyle | CenterPoint Energy | 52 | |
| David Campbell | Vistra Energy Corp | 50 | |
| William Rogers | CenterPoint Energy | 57 | |
| Joseph Vortherms | CenterPoint Energy | 58 | |
| Nicolas Mordeglia | Transportadora de Gas | N/A | |
| Paul Abel | Suburban Propane Partners | 63 | |
| Sara Graziano | Vistra Energy Corp | 35 | |
| Scott Hudson | Vistra Energy Corp | 60 | |
| Stephen Muscato | Vistra Energy Corp | 53 | |
| Patrick Collins | NETGEAR | 44 | |
Management Performance
| Return On Equity | -167.38 | |||
| Return On Asset | -9.82 |
Endologix Leadership Team
Elected by the shareholders, the Endologix's board of directors comprises two types of representatives: Endologix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Endologix. The board's role is to monitor Endologix's management team and ensure that shareholders' interests are well served. Endologix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Endologix's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christopher Chavez, Director | ||
| Greg Morrow, Chief Marketing Officer | ||
| John McDermott, Chairman of the Board, CEO | ||
| Patrick Stephens, Vice President - Research and Development | ||
| Leslie Norwalk, Director | ||
| Matthew Thompson, Chief Medical Officer | ||
| Gregory Waller, Independent Director | ||
| Jeffrey Stelk, Vice President - U.S. Sales | ||
| Guido Neels, Independent Director | ||
| Joseph DeJohn, Vice President - Sales | ||
| Michael Maszy, Vice President - Manufacturing | ||
| Shari OQuinn, Vice President - Regulatory and Quality Affairs | ||
| Charles Love, Vice President - Clinical Affairs | ||
| Janet Fauls, Director - Regulatory Affairs | ||
| John Onopchenko, COO | ||
| James Machek, Vice President - Research and Development | ||
| David Jennings, VP of HR | ||
| Vaseem Mahboob, CFO | ||
| Thomas Zenty, Independent Director | ||
| Amanda DePalma, VP of Global Marketing | ||
| Jose Lima, VP of Quality | ||
| Cecille Ferracci, General Manager - Europe | ||
| Jeff Fecho, Chief Quality Officer | ||
| Todd Abraham, Vice President - Operations | ||
| Michael Chobotov, CTO | ||
| Meredith Huetter, Vice President - Global Medical Affairs | ||
| Thomas Wilder, Independent Director | ||
| Daniel Lemaitre, Lead Independent Director | ||
| Robert Mitchell, President | ||
| Laura Nagel, Vice President - Global Quality | ||
| Jeremy Hayden, General Counsel, Corporate Secretary |
Endologix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Endologix a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -167.38 | |||
| Return On Asset | -9.82 | |||
| Profit Margin | (44.65) % | |||
| Operating Margin | (33.99) % | |||
| Current Valuation | 159.27 M | |||
| Shares Outstanding | 19.17 M | |||
| Shares Owned By Insiders | 4.69 % | |||
| Shares Owned By Institutions | 74.71 % | |||
| Number Of Shares Shorted | 343.57 K | |||
| Price To Earning | (5.55) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Endologix in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Endologix's short interest history, or implied volatility extrapolated from Endologix options trading.
Pair Trading with Endologix
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Endologix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Endologix will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Vulcan Materials could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vulcan Materials when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vulcan Materials - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vulcan Materials to buy it.
The correlation of Vulcan Materials is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vulcan Materials moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vulcan Materials moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vulcan Materials can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Endologix information on this page should be used as a complementary analysis to other Endologix's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Endologix Stock
If you are still planning to invest in Endologix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Endologix's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |